Heping Lei

Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease

S. Zhong, M. Huang, Q. Ma, 2020, Clinical and translational medicine.

Update of Indoles: Promising molecules for ameliorating metabolic diseases.

Zhongyi Zhang, Guanyu Yan, Y. Zhu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Simultaneous determination of atorvastatin and its metabolites in human plasma by UPLC-MS/MS

S. Zhong, Lan Tang, Zhijie Zheng, 2017 .

Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models.

Meng Li, Yicheng Mao, Y. Zhu, 2021, Pharmacological research.

Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden death.

Hang Qi, Yongzheng Peng, Ruiling Feng, 2017, Journal of electrocardiology.

High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease

S. Zhong, Yong Liu, Bin Zhang, 2018, Front. Pharmacol..

Genome‐wide association study of metabolites in patients with coronary artery disease identified novel metabolite quantitative trait loci

S. Zhong, Q. Ma, Xiaoping Chen, 2021, Clinical and translational medicine.